-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Nurix Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2021 to Q1 2025.
- Nurix Therapeutics, Inc. Operating Lease, Payments for the quarter ending 28 Feb 2025 was $2.15M, a 12.1% increase year-over-year.
- Nurix Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $8.32M, a 19.3% increase from 2023.
- Nurix Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $6.97M, a 6.01% increase from 2022.
- Nurix Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $6.58M, a 63.4% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)